Back to Search
ERIC DONALD, PH.D CANDIDATE
PH.D CANDIDATE
Technician
NPI: 1902363401Individual
Specialties, Licenses & Credentials
TechnicianPrimary
Technician
Code: 374700000X
Research & Publications (7)
In vivo sensitized and in vitro activated B cells mediate tumor regression in cancer adoptive immunotherapy.
PMID 19667089·J Immunol·2009
7-preclinical
A multidisciplinary audit of clinical coding accuracy in otolaryngology: financial, managerial and clinical governance considerations under payment-by-results.
PMID 19260884·Clin Otolaryngol·2009
8-other
A European pharmaceutical company initiative challenging the regulatory requirement for acute toxicity studies in pharmaceutical drug development.
PMID 18295384·Regul Toxicol Pharmacol·2008
7-preclinical
Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer.
PMID 17075123·J Clin Oncol·2006
3-trial
Simultaneous targeting of CD3 on T cells and CD40 on B or dendritic cells augments the antitumor reactivity of tumor-primed lymph node cells.
PMID 16034078·J Immunol·2005
7-preclinical
Characterization of a naturally-occurring polymorphism in the UHR-1 gene encoding the putative rat prolactin-releasing peptide receptor.
PMID 15752583·Peptides·2005
7-preclinical
Synergistic effects of IL-12 and IL-18 in skewing tumor-reactive T-cell responses towards a type 1 pattern.
PMID 15705908·Cancer Res·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 28945 BIRCHLAWN ST
GARDEN CITY, MI 48135 - Phone
- (734) 772-4009
Quick Facts
- NPI
- 1902363401
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 7
Are you this provider?
Claim Your Profile